Macdonald Guy
Insider CIK 1296998 · SCYX Director · TTPH President and Chief Executive, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS INC | A Award deriv | 2026-06-26 | 2026-06-30 | 2,875 | — | $0 | 2,875 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2026-06-26 | 2026-06-30 | 2,875 | — | $0 | 12,625 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 78,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 55,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2023-06-15 | 2023-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2023-06-15 | 2023-06-23 | 10,000 | — | $0 | 32,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 22,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2021-06-16 | 2021-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-12-21 | 2020-12-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-12-21 | 2020-12-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2020-12-21 | 2020-12-23 | 8,000 | $6.25 | $50.0K | 12,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | U Tender | 2020-07-28 | 2020-07-29 | 15,703 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2021-03-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2020-07-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2019-12-06 | 2019-12-09 | 5,735 | $2.25 | $12.9K | 250 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2019-12-05 | 2019-12-09 | 1,870 | $2.34 | $4.4K | 5,985 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-06-18 | 2019-06-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-01-17 | 2019-01-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-01-17 | 2019-01-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-01-02 | 2019-01-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2018-11-14 | 2019-01-18 | 3,332 | — | $0 | 134,396 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-10-01 | 2018-10-03 | 21,595 | $0.79 | $17.1K | 21,595 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-07-02 | 2018-07-03 | 15,589 | $1.10 | $17.1K | 15,589 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2018-05-14 | 2019-01-18 | 2,058 | — | $0 | 131,064 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-04-02 | 2018-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-04-02 | 2018-04-04 | 19,959 | $0.86 | $17.2K | 19,959 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-01-19 | 2018-01-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-01-19 | 2018-01-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 19,989 | — | $0 | 19,989 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 11,555 | $1.48 | $17.1K | 11,555 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2017-11-14 | 2018-01-19 | 1,566 | — | $0 | 129,006 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-10-02 | 2017-10-04 | 10,709 | — | $0 | 10,709 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-07-03 | 2017-07-05 | 14,396 | — | $0 | 14,396 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2017-05-12 | 2018-01-19 | 3,101 | — | $0 | 127,440 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-04-03 | 2017-04-04 | 9,941 | — | $0 | 9,941 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2017-02-09 | 2017-02-13 | 30,378 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2017-02-09 | 2017-02-13 | 30,378 | $2.90 | $88.1K | 124,339 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-31 | 2017-02-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-31 | 2017-02-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-03 | 2017-01-05 | 14,499 | — | $0 | 14,499 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-03 | 2017-01-05 | 7,749 | — | $0 | 7,749 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2016-11-14 | 2017-02-01 | 3,204 | — | $0 | 93,961 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-10-03 | 2016-10-04 | 6,255 | — | $0 | 6,255 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-07-01 | 2016-07-11 | 12,996 | — | $0 | 12,996 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy deriv | 2016-06-24 | 2016-06-28 | 18,000 | $0.02 | $360 | 18,000 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2016-06-24 | 2016-06-28 | 40,000 | $2.39 | $95.6K | 40,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-06-02 | 2016-06-06 | 8,800 | $3.98 | $35.0K | 8,800 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2016-05-16 | 2016-05-18 | 25,323 | — | $0 | 20,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2016-05-16 | 2016-05-18 | 25,323 | $0.87 | $22.0K | 90,757 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-04-01 | 2016-04-05 | 7,027 | — | $0 | 7,027 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-01-06 | 2016-01-08 | 300,000 | — | $0 | 300,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2016-01-06 | 2016-01-08 | 12,000 | — | $0 | 45,323 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2016-01-06 | 2016-01-08 | 12,000 | $0.87 | $10.4K | 64,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-01-04 | 2016-01-06 | 4,666 | — | $0 | 4,666 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-10-01 | 2015-10-05 | 4,286 | — | $0 | 4,286 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-09-01 | 2015-09-03 | 10,000 | — | $0 | 180,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-09-01 | 2015-09-03 | 10,000 | $41.57 | $415.7K | 52,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-09-01 | 2015-09-03 | 10,000 | $7.94 | $79.4K | 62,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-08-24 | 2015-08-25 | 12,000 | — | $0 | 57,323 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-08-24 | 2015-08-25 | 12,000 | $0.87 | $10.4K | 52,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-08-06 | 2015-08-07 | 30,000 | $43.65 | $1.31M | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-08-03 | 2015-08-03 | 10,000 | — | $0 | 190,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-08-03 | 2015-08-03 | 10,000 | $7.94 | $79.4K | 80,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-08-03 | 2015-08-03 | 10,000 | $47.45 | $474.5K | 70,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-07-20 | 2015-07-22 | 15,000 | $50.72 | $760.8K | 70,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-07-01 | 2015-07-02 | 10,000 | — | $0 | 200,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-07-01 | 2015-07-06 | 2,974 | — | $0 | 2,974 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-07-01 | 2015-07-02 | 10,000 | $7.94 | $79.4K | 95,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-07-01 | 2015-07-02 | 10,000 | $47.92 | $479.2K | 85,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-06-04 | 2015-06-05 | 8,800 | — | $0 | 8,800 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-06-01 | 2015-06-03 | 5,000 | — | $0 | 84,323 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-06-01 | 2015-06-03 | 15,000 | — | $0 | 69,323 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-06-01 | 2015-06-03 | 10,000 | — | $0 | 210,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-06-01 | 2015-06-03 | 20,000 | $0.87 | $17.4K | 90,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-01 | 2015-06-03 | 5,000 | $41.92 | $209.6K | 85,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-01 | 2015-06-03 | 1,087 | $41.98 | $45.6K | 70,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-06-01 | 2015-06-03 | 10,000 | $7.94 | $79.4K | 81,087 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-01 | 2015-06-03 | 10,000 | $41.86 | $418.6K | 71,087 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-05-11 | 2015-05-13 | 20,000 | — | $0 | 220,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-05-11 | 2015-05-13 | 20,000 | $41.51 | $830.2K | 70,537 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-05-11 | 2015-05-13 | 20,000 | $7.94 | $158.8K | 90,537 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-04-01 | 2015-04-03 | 1,976 | — | $0 | 1,976 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-03-26 | 2015-03-27 | 20,000 | — | $0 | 89,323 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-03-26 | 2015-03-27 | 20,000 | $0.87 | $17.4K | 70,537 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-03-02 | 2015-03-04 | 10,000 | — | $0 | 240,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-03-02 | 2015-03-04 | 200 | $38.90 | $7.8K | 60,337 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-03-02 | 2015-03-04 | 10,000 | $7.94 | $79.4K | 60,537 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-03-02 | 2015-03-04 | 9,800 | $39.67 | $388.8K | 50,537 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-02-02 | 2015-02-04 | 10,000 | — | $0 | 250,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-02-02 | 2015-02-04 | 10,000 | $7.94 | $79.4K | 60,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-02-02 | 2015-02-04 | 7,600 | $35.09 | $266.7K | 50,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-02-02 | 2015-02-04 | 2,400 | $35.93 | $86.2K | 57,600 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-01-20 | 2015-01-22 | 1,256 | — | $0 | 25,834 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-01-20 | 2015-01-22 | 22,030 | — | $0 | 57,331 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-01-20 | 2015-01-22 | 849 | — | $0 | 109,323 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-01-20 | 2015-01-22 | 10,000 | — | $0 | 260,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-01-20 | 2015-01-22 | 10,000 | $7.94 | $79.4K | 60,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-01-20 | 2015-01-22 | 34,135 | $36.59 | $1.25M | 50,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-01-20 | 2015-01-22 | 849 | $0.87 | $739 | 60,849 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-01-20 | 2015-01-22 | 22,030 | $2.03 | $44.7K | 82,879 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-01-20 | 2015-01-22 | 1,256 | $5.80 | $7.3K | 84,135 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-01-07 | 2015-01-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-01-02 | 2015-01-06 | 1,738 | — | $0 | 1,738 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2014-12-02 | 2014-12-04 | 7,830 | — | $0 | 7,830 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-09-23 | 2014-09-25 | 9,641 | — | $0 | 79,361 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-09-23 | 2014-09-25 | 359 | — | $0 | 12,534 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-09-23 | 2014-09-25 | 9,641 | $2.03 | $19.6K | 59,641 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-09-23 | 2014-09-25 | 359 | $2.03 | $729 | 60,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-23 | 2014-09-25 | 10,000 | $18.47 | $184.7K | 50,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-09-17 | 2014-09-18 | 10,000 | — | $0 | 110,172 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-17 | 2014-09-18 | 10,000 | $18.00 | $180.0K | 50,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-09-17 | 2014-09-18 | 10,000 | $0.87 | $8.7K | 60,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-08-20 | 2014-08-22 | 10,000 | — | $0 | 120,172 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-08-20 | 2014-08-22 | 10,000 | $0.87 | $8.7K | 60,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-08-20 | 2014-08-22 | 10,000 | $11.59 | $115.9K | 50,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-08-05 | 2014-08-07 | 25,000 | — | $0 | 130,172 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-08-05 | 2014-08-07 | 25,000 | $0.87 | $21.8K | 50,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-07-18 | 2014-07-22 | 40,000 | — | $0 | 155,172 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-07-18 | 2014-07-22 | 40,000 | $0.87 | $34.8K | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-07-18 | 2014-07-22 | 15,000 | $10.61 | $159.2K | 25,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-06-17 | 2014-06-19 | 15,000 | — | $0 | 35,849 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-06-17 | 2014-06-19 | 15,000 | $12.28 | $184.2K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-06-17 | 2014-06-19 | 15,000 | $0.87 | $13.1K | 15,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-05-19 | 2014-05-21 | 15,000 | — | $0 | 50,849 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-05-19 | 2014-05-21 | 15,000 | $9.00 | $135.0K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-05-19 | 2014-05-21 | 15,000 | $0.87 | $13.1K | 15,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-04-14 | 2014-04-16 | 15,000 | — | $0 | 65,849 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-04-14 | 2014-04-16 | 15,000 | $0.87 | $13.1K | 15,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-04-14 | 2014-04-16 | 15,000 | $9.69 | $145.3K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2014-02-10 | 2014-02-12 | 15,000 | — | $0 | 80,849 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-12 | 15,000 | $14.42 | $216.3K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2014-02-10 | 2014-02-12 | 15,000 | $0.87 | $13.1K | 15,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-01-08 | 2014-01-10 | 160,000 | — | $0 | 160,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2013-05-15 | 2013-05-17 | 270,000 | — | $0 | 270,000 | SEC↗ |